Asset Details
Do you wish to reserve the book?
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Do you wish to request the book?
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
2001
Overview
Heart failure is a substantial public health problem among black Americans. It is more common in the black population than in other populations in the United States, affecting approximately 3 percent of all black adults in this country.
1
,
2
Symptoms of heart failure develop in blacks at an earlier age than they do in nonblacks,
3
–
5
possibly because blacks are more likely to have hypertension and diabetes and to have ventricular hypertrophy and vascular injury than nonblacks.
5
–
8
Once diagnosed, heart failure progresses more rapidly in black patients than in white patients, as evidenced by the higher risk of initial . . .
Publisher
Massachusetts Medical Society
Subject
Adrenergic Antagonists - adverse effects
/ Adrenergic Antagonists - pharmacology
/ Adrenergic Antagonists - therapeutic use
/ African Continental Ancestry Group
/ Antianginal agents. Coronary vasodilator agents
/ Biological and medical sciences
/ Carbazoles - adverse effects
/ Carbazoles - therapeutic use
/ Continental Population Groups
/ Female
/ Heart Failure - drug therapy
/ Heart Failure - physiopathology
/ Hospitalization - statistics & numerical data
/ Humans
/ Male
/ Pharmacology. Drug treatments
/ Propanolamines - adverse effects
/ Propanolamines - pharmacology
/ Propanolamines - therapeutic use
